Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
Procter & Gamble CEO – Beauty Freddy Bharucha has reported his equity holdings in the company. He directly owns 1,345.0358 shares of Procter & Gamble common stock and indirectly holds additional shares through a retirement plan trustee and through his spouse. Indirect common stock holdings include 5,051.056 shares held by a retirement plan trustee, 370.6 shares held by his spouse, 3,444.125 shares held by his spouse and a retirement plan trustee, and 895.98 shares held by his spouse through international stock ownership and pension plans.
The filing also lists a range of stock options and restricted stock units tied to Procter & Gamble common stock, with various exercise prices and expiration dates, some held directly and some through his spouse. In addition, Series A preferred stock positions are shown in retirement plan accounts, which may convert to common stock under specified plan provisions.
Procter & Gamble (PG) reported an insider transaction by its Chief Financial Officer. On 11/10/2025, the reporting person executed a sale (Code S) of 1.2969 shares of common stock at $146.3745 per share. The transaction was held indirectly through a Retirement Plan Trustee. Following this trade, the filer reported 6,869.3576 shares indirect and 53,992.0273 shares direct beneficial ownership.
Procter & Gamble (PG): Form 4 insider transaction
Officer Ma. Fatima Francisco (CEO - Baby, Fem & Family Care) reported a transfer of 12,731 shares of common stock on 11/05/2025, recorded with transaction code G at a price of $0. The filing notes this reflects the transfer of 12,731 shares for no consideration to a spousal lifetime access trust (the “SLAT”).
Following the transaction, holdings reported include 14,564.0856 shares directly, 12,731 indirectly by SLAT, 15,998.3673 indirectly by Retirement Plan Trustee, and 2,862.8125 indirectly by Spouse/Retirement Plan Trustees.
Procter & Gamble closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under its Form S-3 shelf registration. The company also filed related legal opinions as exhibits.
This transaction adds very long-dated debt to P&G’s capital structure, extending maturities far into the future. The filing lists counsel opinions from the Company and from Fried, Frank, Harris, Shriver & Jacobson LLP, which are incorporated by reference.
Procter & Gamble (PG) closed underwritten public offerings of four tranches of senior notes under its Form S-3 shelf. The company issued €500,000,000 of 2.900% Notes due November 3, 2033 and €500,000,000 of 3.650% Notes due November 3, 2045. It also issued $750,000,000 of 4.100% Notes due November 3, 2032 and $500,000,000 of 4.350% Notes due November 3, 2035.
These multi-currency, multi-maturity offerings expand PG’s debt stack in euros and U.S. dollars, locking in fixed coupons across maturities from 2032 to 2045. Legal opinions for each series are included as exhibits.
The Procter & Gamble Company is offering $258,889,000 of Floating Rate Notes due 2075 under a prospectus supplement. The notes pay interest quarterly at Compounded SOFR minus 0.45% per year, with a 0.00% floor, starting on February 4, 2026, and mature on November 4, 2075.
The notes are priced at 100.000% with a 1.000% underwriting discount, for proceeds to the company of $256,300,110 before expenses. They are expected to settle through DTC on or about November 4, 2025 and will not be listed on any exchange.
P&G may redeem the notes, in whole or in part, beginning November 4, 2055 at step-down prices from 105.00% to 100.00% by 2065 and thereafter at par. Holders may require repurchase beginning November 4, 2026 annually through 2036 at 98.00%–100.00%, and every third year thereafter at 100.00%. Upon a defined tax event, P&G may shorten the maturity to preserve U.S. interest deductibility, paying 100% of principal plus accrued interest on the new maturity date.
Procter & Gamble (PG) reported an insider transaction on a Form 4. The company’s SVP – Chief Accounting Officer sold 725 shares of Common Stock on 10/30/2025 at $149.57 per share (transaction code S).
Following the sale, the reporting person beneficially owned 978.9031 shares directly and 3,293.5342 shares indirectly by Retirement Plan Trustee. The filing indicates it was submitted by an attorney‑in‑fact.
The Procter & Gamble Company launched a registered debt offering of $1,250,000,000, consisting of $750,000,000 4.100% notes due November 3, 2032 and $500,000,000 4.350% notes due November 3, 2035. Interest accrues from November 3, 2025 and is payable semiannually on May 3 and November 3, with the first payment on May 3, 2026. The notes are not listed on any exchange.
Initial offering prices were 99.916% (2032s) and 99.831% (2035s), with underwriting discounts of 0.400% and 0.450%, respectively. Total proceeds to the company before expenses are $1,243,275,000. The notes are optionally redeemable at a make-whole price based on the Treasury Rate +5 bps (2032s) and Treasury Rate +10 bps (2035s), or at 100% of principal, in each case plus accrued interest to, but excluding, the redemption date.
Delivery is expected through DTC, Clearstream and Euroclear on or about November 3, 2025. Recent quarterly results (three months ended September 30, 2025) show net sales of $22,386 million and net earnings attributable to P&G of $4,750 million.
The Procter & Gamble Company priced a primary offering of €1,000,000,000 senior euro notes in two tranches: €500,000,000 of 2.900% notes due November 3, 2033 and €500,000,000 of 3.650% notes due November 3, 2045. Interest accrues from November 3, 2025 and is payable annually in arrears, with the first payment on November 3, 2026.
The pricing table shows initial offering prices of 99.761% (2033) and 99.916% (2045), underwriting discounts of 0.338% and 0.500%, and aggregate proceeds to the issuer before expenses of €994,195,000. The notes are optionally redeemable at a make‑whole amount based on the applicable Comparable Government Bond Rate plus 10 bps. Application will be made to list the notes on the NYSE, subject to approval. The notes will clear through Clearstream and Euroclear and will be issued in €100,000 denominations (and €1,000 multiples thereafter).
The Procter & Gamble Company: a stockholder filed a Form 144 for a proposed sale of 725 shares of common stock with an aggregate market value of $110,123.88. The approximate sale date is October 30, 2025, to be executed on the NYSE through Morgan Stanley Smith Barney LLC.
The filer reported acquiring 1,044 shares on August 18, 2025 via a Performance Stock Program Award. In the past three months, the filer reported a sale of 319 shares on August 19, 2025 for $50,170.34 in gross proceeds.
Shares outstanding were 2,336,733,549; this is a baseline figure, not the amount being offered.
FAQ
What is the current stock price of Procter & Gamble (PG)?
What is the market cap of Procter & Gamble (PG)?
